April 21, 2023

Oxford PharmaGenesis honoured with prestigious King's Award for Enterprise

Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country, which recognizes the company’s excellence in International Trade.

The King’s Awards celebrate the success of exciting and innovative businesses, which are leading the way with pioneering products or services, delivering impressive social mobility programmes or showing their commitment to excellent sustainable development practices.

  • All
  • News
  • Articles
  • Events

Pharmaceutical companies reduce own greenhouse gas emissions, but action on supply chains needed

DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public Health this month, revealing the climate change targets of the 20 leading global pharmaceutical companies – and how they are reporting on and reducing their…

Continue reading

A Great Place to Work® for 2022–2023: Oxford PharmaGenesis awarded certification for another year running

Oxford PharmaGenesis has secured Great Place to Work® accreditation for a third consecutive year in the UK and a seventh consecutive year in the US. This was awarded based on average scores across a number of statements and 90% of colleagues who responded to the survey agreed that “Taking everything into account, I would say this is a great place to work”.

Continue reading

Accessibility, virality and healthy debate: our ISMPP EU 2023 conference report

The ISMPP EU conference took place in London on 24–25 January. Themed around ‘Fueling Creativity’, sessions explored how to access creativity, improve collaboration and arrive at unexpected solutions.

Continue reading

2023 European Meeting of ISMPP, London UK

Join our healthy debate at the 2023 European Meeting of ISMPP and explore new frontiers with Oxford PharmaGenesis.

Continue reading

Keeping evidence current: living systematic reviews

To ensure that patients receive optimal healthcare, clinicians rely on the best available evidence, which is often synthesized in a systematic literature review (SLR) or meta-analysis. The problem is that research never stands still, so new findings are constantly being published. This means that unless an SLR is continually updated, new findings may remain buried…

Continue reading

APPA-MAPS 22: highlights of the inaugural ANZ Medical Affairs summit

Space medicine, digital health and the patient voice were just some of the topics explored at the inaugural 2022 Australian Pharmaceutical Professionals Association (APPA) and Medical Affairs Professional Society (MAPS) joint Medical Affairs summit for the Australia and New Zealand (ANZ) region, held on 17 and 18 November in Sydney, Australia.

Continue reading